RSV Vaccines + Patient Experience Data
Ronda Miller-Ernest, a Pediatric Nurse Practitioner for more than 30 years, discusses the importance of RSV vaccines and the Vaccines for Children Program in the wake of an ACIP meeting; the FDA has opened up its public comment period for guidance...
Ronda Miller-Ernest, a Pediatric Nurse Practitioner for more than 30 years, discusses the importance of RSV vaccines and the Vaccines for Children Program in the wake of an ACIP meeting; the FDA has opened up its public comment period for guidance regarding how to incorporate patient experiences into the drug development and regulatory review process; Jodie Solari, Communications Lead for the Galactosemia Foundation, explains a clinical trial took place where the drug did not meet all of the FDA’s established markers, but the improvements to families should not be ignored; and the FDA and several other agencies are some of the few recipients of increased funding thanks to a new bill from the Senate Committee on Appropriations.
Patients Rising Podcast Webpage: The Fight Against RSV Revs Up
CDC Webpage: ACIP Presentation Slides – June 21-23, 2023 Meeting
Ronda Miller-Ernest
Retired Pediatric Nurse Practitioner
Jodie Solari
Mom of daughters living with galactosemia
Communications at the Galactosemia Foundation and a mother of three daughters, two of which live with this rare disease.
Listen On
